Enveric Biosciences, Inc.
ENVBNasdaqHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Lind Global Fund Iii LpPassive (13G)May 15, 2026
- Intracoastal Capital, LlcPassive (13G)Feb 2, 2026
- Advisorshares TrustPassive (13G)Jan 5, 2026
- Braeden LichtiPassive (13G)Dec 10, 2025
- Northstrive Fund Ii LpPassive (13G)Dec 10, 2025
- Ayrton Capital LlcPassive (13G)Nov 13, 2025
- Orca Capital AgPassive (13G)Feb 4, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 115,974 | 1.0 | -86.9% |
| Apr 30, 2026 | 886,509 | 1.0 | +1306.6% |
| Apr 15, 2026 | 63,023 | 2.3 | -10.9% |
| Mar 31, 2026 | 70,703 | 2.2 | -24.8% |
| Mar 13, 2026 | 93,975 | 1.8 | -20.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.